Steven Attia Selected Research

Steven Attia Research Topics

Disease

22	Neoplasms (Cancer) 03/2024 - 06/2009
21	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 05/2010
8	Disease Progression 01/2024 - 01/2017
6	Fatigue 03/2024 - 12/2018
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2024 - 11/2020
5	Diarrhea 03/2024 - 01/2008
5	Liposarcoma 01/2022 - 05/2015
4	Leiomyosarcoma 04/2024 - 01/2018
4	Nausea 03/2024 - 01/2022
4	Hemangiosarcoma (Angiosarcoma) 01/2022 - 10/2014
3	Synovial Sarcoma (Synovioma) 03/2024 - 01/2018
3	Exanthema (Rash) 03/2024 - 12/2018
3	Pain (Aches) 03/2024 - 08/2021
3	Aggressive Fibromatosis (Desmoid) 03/2023 - 12/2018
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2023 - 05/2015
3	Hypertension (High Blood Pressure) 01/2022 - 12/2018
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 05/2015
3	Prostatic Neoplasms (Prostate Cancer) 06/2009 - 09/2006
2	Myxoid Liposarcoma 03/2024 - 01/2022
2	Constipation 03/2024 - 10/2023
2	Alopecia (Baldness) 03/2024 - 12/2022
2	Vomiting 03/2024 - 01/2022
2	Hypophosphatemia 03/2023 - 01/2023
2	Anemia 01/2022 - 11/2021
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2017
2	Neutropenia 01/2017 - 06/2009
1	Edema (Dropsy) 03/2024
1	Pneumonia (Pneumonitis) 03/2024
1	Epithelioid Hemangioendothelioma 03/2024
1	Epistaxis (Nosebleed) 01/2022
1	Headache (Headaches) 01/2022
1	Abdominal Pain (Pain, Abdominal) 11/2021
1	Chordoma 01/2021
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 12/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Dehydration (Water Stress) 01/2020
1	Lactic Acidosis 01/2017
1	Heart Failure 01/2017
1	Febrile Neutropenia 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Sepsis (Septicemia) 01/2017

Drug/Important Bio-Agent (IBA)

7	ripretinibIBA 01/2024 - 01/2020
6	regorafenibIBA 01/2023 - 05/2015
6	pazopanib FDA Link 01/2022 - 11/2014
4	Gemcitabine FDA Link 10/2023 - 08/2008
4	Phosphotransferases (Kinase)IBA 01/2023 - 05/2015
3	Sunitinib (Sutent)FDA Link 01/2024 - 12/2022
3	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 12/2020
3	Docetaxel (Taxotere)FDA Link 10/2023 - 04/2008
2	Dacarbazine (DIC)FDA LinkGeneric 04/2024 - 12/2023
2	AnthracyclinesIBA 03/2024 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 12/2022 - 12/2021
2	selinexorIBA 01/2022 - 08/2021
2	B7-H1 AntigenIBA 01/2022 - 01/2018
2	pembrolizumabIBA 01/2020 - 11/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 03/2016
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2009 - 08/2008
2	Proteins (Proteins, Gene)FDA Link 06/2009 - 08/2008
1	PTC596IBA 04/2024
1	Ifosfamide FDA LinkGeneric 03/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2024
1	HLA-A Antigens (HLA-A)IBA 03/2024
1	trametinibIBA 03/2024
1	Opiate AlkaloidsIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	olaratumabIBA 10/2023
1	nirogacestatIBA 03/2023
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2023
1	Triamcinolone (Aristocort)FDA Link 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	olaparibIBA 01/2023
1	carotuximabIBA 01/2022
1	atezolizumabIBA 01/2022
1	Circulating Tumor DNAIBA 12/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	mesoglycanIBA 01/2021
1	tazemetostatIBA 11/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	ontuxizumabIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	TabletsIBA 12/2018
1	Sorafenib (BAY 43-9006)FDA Link 12/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 07/2017

Therapy/Procedure

14	Therapeutics 03/2024 - 10/2014
8	Drug Therapy (Chemotherapy) 03/2024 - 08/2008
2	Immunotherapy 03/2023 - 07/2020
2	Aftercare (After-Treatment) 12/2022 - 05/2011
2	Radiotherapy 01/2021 - 10/2014
1	Heavy Ion Radiotherapy 03/2023
1	Proton Therapy 03/2023
1	Intralesional Injections 01/2023
1	Injections 01/2023
1	Drug Tapering 01/2023
1	Duration of Therapy 11/2021